Abstract
The efficacy of penicillin G was evaluated in the prevention of infections caused by streptococci in patients receiving remission induction or intensive consolidation treatment for acute myeloid leukaemia. Between 1980 and 1988, 29 episodes of streptococcal septicaemia occurred in 139 treatment events. All patients received as prophylaxis regimen ciprofloxacin (n=38) or a combination of polymyxin B with nalidixic acid (n=42) or neomycin (n=59). Six patients died of streptococcal septicaemia despite adequate antibiotic treatment. The high incidence of streptococcal septicaemia lead to the administration of penicillin G in addition to ciprofloxacin as prophylaxis regimen during the 14 days immediately following cytotoxic chemotherapy. Only two episodes of streptococcal septicaemia were documented after addition of penicillin G to the prophylaxis regimen (n=76, p<0.001). Both patients had an uneventful recovery after treatment with vancomycin. Patients receiving penicillin G prophylaxis experienced fever during 17 % of the time and received antimicrobial therapy during 20 % of the time per treatment event compared with 27 % and 32 % respectively of this time in patients receiving no streptococcal prophylaxis (p<0.001). Penicillin G prophylaxis was associated with an increased incidence of fever of unknown origin and more frequent isolation of aerobic gram-negative bacteria in surveillance cultures. Penicillin G in combination with ciprofloxacin proved to be highly successful in preventing infections caused by streptococci and in reducing infection-related mortality and morbidity.
Article PDF
Similar content being viewed by others
References
Cohen J, Worsley AM, Goldman JM, Donnelly JP, Catovsky D, Galton DAG: Septicaemia caused by viridans streptocci in neutropenic patients with leukaemia. Lancet 1983, ii: 1452–1454.
Kern W, Kurrle E, Vanek E: High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia. Klinische Wochenschrift 1987, 65: 773–780.
Menichetti F, Del Favero A, Guerciolini R, Tonato M, Frongillo RF, Roila F, Pauluzzi S: Viridans streptococci septicemia in cancer patients: a clinical study. European Journal of Epidemiology 1987, 3: 316–318.
Van der Lelie H, van Ketel RJ, von dem Borne AEGK, van Oers RHJ, Thomas BLM, Goudsmit R: Incidence and clinical epidemiology of streptococcal septicemia during treatment of acute myeloid leukemia. Scandinavian Journal of Infectious Diseases 1991, 23: 163–168.
Dybedal I, Lamvik J: Respiratory insufficiency in acute leukemia following treatment with cytosine arabinoside and septicemia withStreptococcus viridans. European Journal of Haematology 1989, 42: 405–406.
Kern W, Kurrle E, Schmeiser T: Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases. Infection 1990, 18: 138–145.
McWhinney PHM, Gillespie SH, Kibbler CC, Hoffbrand AV, Prentice HG:Streptococcus mitis and ARDS in neutropenic patients. Lancet 1991, 337: 429.
Arning M, Gehrt A, Aul C, Runde V, Hadding U, Schneider W: Septicemia due toStreptococcus mitis in neutropenic patients with acute leukemia. Blut 1990, 61: 364–368.
Henslee J, Bostrom B, Weisdorf D, Ramsay N, McGlave P, Kersey J: Streptococcal sepsis in bone marrow transplant patients. Lancet 1984, i: 393.
Classen DC, Burke JP, Ford CD, Evershed S, Aloia MR, Wilfahrt JK, Elliott JA:Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. American Journal of Medicine 1990, 89: 441–446.
Rozenberg-Arska M, Dekker A, Verdonck L, Verhoef J: Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28965) in granulocytopenic patients receiving ciprofloxacin. Infection 1989, 17: 240–244.
Guiot HFL, Peters WG, van den Broek PJ, van der Meer, JWM, Kramps JA, Willemze R, van Furth R: Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin. Infection 1990, 18: 131–137.
Karp JE, Dick JD, Angelopulos C, Charache P, Green L, Burke PJ, Saral R: Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. American Journal of Medicin 1986, 81: 237–242.
Heimdahl A, Mattsson T, Dahllöf G, Lönnquist B, Ringden O: The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation. Oral Surgery, Oral Medicine, Oral Pathology 1989, 68: 711–716.
Wade JC, Schimpff SC, Newman KA, Wiernik PH:Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Annals of Internal Medicine 1982, 97: 503–508.
Rubin M, Hathorn JW, Marshall D, Gress J, Steinberg SM, Pizzo PA: Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Annals of Internal Medicine 1988, 108: 30–35.
Guiot HFL, van der Meer JWM, van den Broek PJ, Willemze R, van Furth R: Prevention of viridans-group streptococccal septicemia in oncohematologic patients: a controlled comparative study on the effect of penicillin G and cotrimoxazole. Annals of Hematology 1992, 64: 260–265.
Santini C, Venditti M, Baiocchi P, Brandimarte C, Serra P, Mandelli F, Girmenia C, Micozzi A, Martino P: Emergence of penicillin-resistant viridans streptococci causing septicemia in granulocytopenic patients. European Journal of Epidemiology 1988, 4: 391–392.
Van de Leur JJJPM, Dofferhoff ASM, van Turnhout JM, Vollaard JE, Clasener HAL: Colonisation of oropharynx with staphylococci after penicillin in neutropenic patients. Lancet 1992, 340: 861–862.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Jong, P., de Jong, M., Kuijper, E. et al. Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy. Eur. J. Clin. Microbiol. Infect. Dis. 12, 750–755 (1993). https://doi.org/10.1007/BF02098462
Issue Date:
DOI: https://doi.org/10.1007/BF02098462